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Selenocysteine (Sec) is the 21st amino acid in the genetic code. Its tRNA is variably methylated on the 2ⴕ-Ohydroxyl site of the ribosyl moiety at position 34 (Um34).
Herein, we identified a role of Um34 in regulating the
expression of some, but not all, selenoproteins. A strain
of knock-out transgenic mice was generated, wherein
the Sec tRNA gene was replaced with either wild type or
mutant Sec tRNA transgenes. The mutant transgene
yielded a tRNA that lacked two base modifications, N6isopentenyladenosine at position 37 (i6A37) and Um34.
Several selenoproteins, including glutathione peroxidases 1 and 3, SelR, and SelT, were not detected in mice
rescued with the mutant transgene, whereas other selenoproteins, including thioredoxin reductases 1 and 3
and glutathione peroxidase 4, were expressed in normal
or reduced levels. Northern blot analysis suggested that
other selenoproteins (e.g. SelW) were also poorly expressed. This novel regulation of protein expression occurred at the level of translation and manifested a tissue-specific pattern. The available data suggest that the
Um34 modification has greater influence than the i6A37
modification in regulating the expression of various
mammalian selenoproteins and Um34 is required for
synthesis of several members of this protein class. Many
proteins that were poorly rescued appear to be involved
in responses to stress, and their expression is also highly
dependent on selenium in the diet. Furthermore, their
mRNA levels are regulated by selenium and are subject
to nonsense-mediated decay. Overall, this study described a novel mechanism of regulation of protein expression by tRNA modification that is in turn regulated
by levels of the trace element, selenium.

The mechanism of selenocysteine (Sec)1 incorporation into
protein as the 21st amino acid was elucidated in Escherichia
coli by Böck (reviewed in Ref. 1). In mammals, the mechanism
of Sec insertion into protein is not as completely understood
(reviewed in Refs. 2 and 3). However, both prokaryotes and
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eukaryotes use the stop codon, UGA, to dictate the incorporation of Sec after the tRNA is initially aminoacylated with
serine, and the biosynthesis of Sec occurs on its tRNA. The
tRNA has therefore been designated Sec tRNA[Ser]Sec (2). The
presence of a stem-loop structure that occurs downstream of
UGA in selenoprotein mRNA, known as a Sec insertion sequence (SECIS) element (4), is responsible for dictating UGA as
Sec instead of the cessation of protein synthesis. In mammals,
a specific SECIS-binding protein, designated SECIS-binding
protein 2 (5), recognizes the SECIS element, and a specific
elongation factor, designated EFsec (6, 7), recognizes selenocysteyl-tRNA[Ser]Sec, and the resulting complex guides Sec into
the nascent polypeptide in response to UGA (2, 3).
In higher vertebrates, there are two Sec tRNA[Ser]Sec isoforms that differ from each other by a single nucleoside modification at position 34, which is the wobble position of the
anticodon (2). One isoform contains methylcarboxylmethyluridine (mcm5U) at this site, and the other contains methylcarboxymethyluridine-2⬘-O-methylribose (mcm5Um). Several
lines of evidence suggest that methylation of the ribosyl moiety at
the 2⬘-O-hydroxyl site (designated Um34) is a highly specialized
event. It is the last step in the maturation of Sec tRNA[Ser]Sec.
This modification step is dependent on the prior synthesis of
the four modified bases found in Sec tRNA[Ser]Sec and on an
intact tertiary structure, whereas synthesis of the other modified nucleosides, including mcm5U, is less stringently connected to primary and tertiary structure (8). The methylation
step is influenced by selenium status, whereby the levels of
mcm5U are enriched and mcm5Um reduced under conditions of
selenium deficiency, and the ratio of the two isoforms is
reversed under conditions of selenium sufficiency (2). The presence of Um34 dramatically affects Sec tRNA[Ser]Sec secondary
and tertiary structure (9). The presence of Um34 on Sec
tRNA[Ser]Sec correlated with the expression of certain selenoproteins (e.g. GPx1) (10, 11), whereas enrichment of the isoform
lacking Um34 correlated with the expression of other selenoproteins (e.g. TR3) (11). In addition, a specialized role of the
selenium-induced, Um34 tRNA[Ser]Sec in selenoprotein translation was recently reported (12). However, the specific role of
this isoform in selenoprotein synthesis has not been elucidated.
The selenoprotein population in rodents is composed of 24
members, and there are 25 members in humans (13). The
function of many of these selenoproteins is not known. However, several approaches have been used in assessing their
function and to provide better insights into their possible roles
in health. Direct assays of selenoproteins such as glutathione
peroxidase 1 (GPx1) and thioredoxin reductase 1 (TR1) demonstrate that they can function as antioxidants (14, 15), whereas
genetic and biochemical characterization of selenoproteins
such as Sep15 (16, 17) and GPx1 (18, 19) suggests that these
members may in addition have roles in cancer prevention.
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Selective Rescue of Selenoproteins
Gene knock-out studies involving selenoproteins in mice show
that some, such as glutathione peroxidase 4 (GPx4) (20), selenoprotein P (SelP) (21, 22), thyroid hormone deiodinase 2 (23),
and mitochondrial thioredoxin reductase (TR3) (24) have essential roles in cellular function, since their removal is lethal or
results in an abnormal phenotypic change. Other selenoproteins, such as GPx1 (25) and glutathione peroxidase 2 (GPx2)
(26), probably have nonessential roles, since their removal
manifests little or no phenotypic change. Exposing animals
lacking a nonessential selenoprotein to stress, however, demonstrates that the animal may not cope with certain stresses
compared with their wild type counterparts (27, 28). Thus,
some selenoproteins that are nonessential to life of the organism probably provide protection from environmental stress.
Several studies have examined the effect of altering Sec
tRNA[Ser]Sec expression on selenoprotein biosynthesis, which
provided another means of elucidating the function of selenoproteins and their roles in health. Removal of trsp in knock-out
mice is embryonic lethal, demonstrating that selenoproteins
are essential to mammalian development (29, 30). Generation
of a conditional knock-out of trsp using loxP-Cre technology has
shown that Sec tRNA[Ser]Sec levels can be reduced in mammary
tissue by about 80%, resulting in an altered selenoprotein
expression in a selenoprotein-specific manner (30), whereas
complete removal of trsp in liver demonstrated that selenoprotein expression is required for proper function of this organ
(31). Overexpression of Sec tRNA[Ser]Sec in transgenic mice
carrying extra copies of the wild type transgene resulted in
little or no effect on selenoprotein expression (11). However,
transgenic mice carrying extra copies of a Sec tRNA[Ser]Sec
mutant transgene that produces a tRNA gene product lacking
N6-isopentenyladenosine (i6A37) at this site and Um34 (8) affect selenoprotein synthesis in a selenoprotein- and tissuespecific manner (11).
In the present study, transgenic mice possessing trsp wild
type or mutant transgenes (11) were used to rescue trsp null
mice (30). Mice dependent on the wild type transgene for survival manifested little or no change in selenoprotein expression, whereas mice dependent on the i6A mutant transgene
rescued only some selenoproteins. Rescued selenoproteins included TR1 and TR3, whereas those that were poorly rescued
included GPx1, GPx3, SelR, SelT, and SelW. Other selenoproteins, such as GPx2, GPx4, SelP, and Sep15, appeared to be
partially rescued. These studies not only show that expression
of some selenoproteins in mammals is highly dependent on
Um34, but generating genetically altered mice that express
reduced levels of a particular subclass of selenoproteins provides a unique model for examining the function of certain
selenoproteins and their possible roles in health.
EXPERIMENTAL PROCEDURES

Materials and Animals—Selenium-75 (specific activity 1000 Ci/
mmol) was obtained from the Research Reactor Facility, University of
Missouri (Columbia, MO); [␣-32P]dCTP (specific activity ⬃6000 Ci/
mmol) was from PerkinElmer Life Sciences; and [3H]serine (specific
activity 29 Ci/mmol) and Hybond Nylon N⫹ membranes were from
Amersham Biosciences. NuPage 10% polyacrylamide gels, polyvinylidene difluoride membranes, Superscript II reverse transcriptase, SeeBlue Plus2-protein markers, and the expressed sequence tag clone used
in making the GPx2 probe (IMAGE Consortium Clone ID 6395265 (AN
BQ961211)) were purchased from Invitrogen, and Universal Reference
RNA was from Stratagene. SuperSignal West Dura extended duration
substrate was obtained from Pierce, PCI-Neo vector was from Promega,
and anti-rabbit horseradish peroxidase- and anti-chicken horseradish
peroxidase-conjugated secondary antibodies were obtained from Sigma.
All other reagents were obtained commercially and were products of the
highest grade available. Mice (strain C57BL/6) that were heterozygous
for the Sec tRNA[Ser]Sec gene (wild type gene is designated as trsp and
the deleted gene as ⌬trsp) were from a previous study in our laboratory
(30), as were the transgenic mice that were either homozygous for the
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wild type transgenes (strain FVB/N) wherein each allele carried 10
copies of the Sec tRNA[Ser]Sec transgene (designated trspt) or for the
mutant Sec tRNA[Ser]Sec transgenes whose product lacked i6A37 and
Um34, wherein each allele carried 20 copies of the mutant transgene
(designated trspti6A⫺) (11). Antibodies against GPx1 were obtained
from Qichang Shen, antibodies against GPx2 were from Regina
Brigelius-Flohé, and antibodies against GPx4 were from Donna
Driscoll, whereas antibodies against TR1, TR3, SelR, SelT, and Sep15
were from our laboratories (13, 32).2 The care of animals was in accordance with the National Institutes of Health institutional guidelines
under the expert direction of Dr. Kyle Stump (NCI, National Institutes
of Health, Bethesda, MD).
Genotyping Mice—DNA was extracted from mouse tail clippings and
the presence or absence of trsp, trspt, and trspti6A⫺ determined by PCR
with the appropriate primers. The forward and reverse primers designated 5FPROA and CKNOR12, respectively, that complement bases
beginning at ⫺2137 bp and ⫺255 bp upstream of the gene (30, 31) were
used to detect trsp (yielding a 1.9-kb PCR fragment). CKNO2, a forward
primer that complements bases beginning at ⫺442 bp upstream of trsp
(30), was used to detect trsp. Two new reverse primers, designated
RES1 (5⬘-ccttgtgagacgaccttctatg-3⬘) and VP1 (5⬘-tgtggaattgtgagcggata3⬘), where RES1 complements bases beginning at ⫹538 bp downstream
of trsp (the 5⬘-end of trsp is base ⫹1) and VP1 corresponds to that
portion of the vector sequence (pBluescript II) retained in the transgene
for monitoring its insertion into the genome (11), were used to monitor,
along with the forward primer, CKNO2, the presence or loss of trsp
(CKNO2-RES1) or trspt and trspti6A⫺ (CKNO2-VP1). CKNO2-RES1
yields a 980-bp PCR trsp fragment and a 500-bp PCR ⌬trsp fragment,
and CKNO2-VP1 yields a 1072-bp PCR trspt or trspti6A⫺ fragment.
Isolation, Aminoacylation, Fractionation, and Quantification of
tRNA and Primer Extension—Total tRNA was isolated from mouse
liver, aminoacylated with [3H]serine and 19 unlabeled amino acids in
the presence of rabbit reticulocyte synthetases (33), the resulting aminoacylated tRNA fractionated on a RPC-5 column (34) in the absence
and subsequently in the presence of Mg2⫹ as given (11, 30). The amount
of Sec tRNA[Ser]Sec expressed from the host trsp or from wild type (trspt)
or mutant (trspti6A⫺) transgenes relative to the total Ser tRNA population and the distributions of mcm5U and mcm5Um has been detailed elsewhere (11, 30). The presence of U at position 9 in host Sec
tRNA[Ser]Sec and of a C at position 9 in the transgene Sec tRNA[Ser]Sec
provided a means of distinguishing host from transgene-generated
tRNA[Ser]Sec by primer extension using either ddG or ddA in the
reaction and the appropriate primer as given (see Ref. 11 and references
therein).
Labeling of Selenoproteins and GPx Activity Assays and Selenium
Assay—Mice were injected intraperitoneally with 50 Ci of 75Se/g and
sacrificed 48 h after injection. Tissues and organs were excised, immediately frozen in liquid nitrogen and stored at ⫺80 °C until ready for
use. Tissues were homogenized, the extracts were electrophoresed
along with molecular weight markers, and the developed gel was
stained with Coomassie Blue, dried, and exposed to a PhosphorImager
as described (see Ref. 31 and references therein).
GPx1–3 activities were measured using a standard assay with hydrogen peroxide as substrate as described previously (11, 30, 31). The
amount of selenium in extracts of liver, heart, brain, and testes was
determined by Oscar E. Olsen Biochemistry Laboratories at South
Dakota State University as described (31).
Northern and Western Blot Analyses—Total RNA was isolated from
liver, kidney, intestine, brain and testes, quantified and loaded onto
gels, and transblotted onto a nylon membrane; the membrane was
hybridized with 32P-labeled probe; and the Northern blot was analyzed
with a PhosphorImager as given (11). GPx1, GPx4, SPS2, D1, TR1, and
SelP probes were prepared and used as described (11). The SelV 733-bp
probe was obtained from James Weaver, who generated it by digestion
of a mouse SelV 1.16-bp XhoI-NotI fragment with BamHI. The remaining probes were generated by RT-PCR using Superscript II reverse
transcriptase and universal reference RNA or mouse liver RNA (11)
with the exception of GPx2, which was generated from an expressed
sequence tag clone (see “Materials and Animals”). Sizes of all RT-PCRgenerated probes were in the 500 –1200-bp range.
Protein extracts were prepared from liver, kidney, brain, testes, and
intestine, electrophoresed on NuPage 10% polyacrylamide gels, transferred to polyvinylidene difluoride membranes, and immunoblotted as
given (11, 30, 31) with antibodies against Gpx1 (1:1000 dilution), Gpx2

2
B. A. Carlson, X.-M. Xu, V. N. Gladyshev, and D. L. Hatfield,
unpublished observations.
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FIG. 1. Sec tRNA[Ser]Sec levels. Transfer RNA was isolated from liver of trsp,
trspt, and trspti6A⫺ mice, aminoacylated
with [3H]serine, and fractionated on an
RPC-5 column as described under “Experimental Procedures.” A single isoform was
present in liver of trspti6A⫺ mice and both
mcm5U and mcm5Um isoforms were present in liver of trsp and trspt mice.

(1:1000), Gpx4 (1:2000), SelR (1:1000), SelT (1:400), Sep15 (1:1000),
TR1 (1:1000), and TR3 (1:1000). Anti-rabbit horseradish peroxidaseconjugated secondary antibody (1:30,000) was used in all Western blots
with the exception of that with TR3, in which anti-chicken horseradish
peroxidase-conjugated secondary antibody (1:10,000) was used. Following the attachment of the secondary antibody, membranes were washed
with 0.1% TBS-T, incubated in SuperSignal West Dura Extended Duration Substrate and exposed to x-ray film.
RESULTS

Generation of Rescued Mice—To determine the role of the
mutant Sec tRNA[Ser]Sec, mice were generated wherein the wild
type Sec tRNA[Ser]Sec gene (trsp) was replaced with several
copies of the mutant transgene (trspti6A⫺), and consequently
the animal’s dependence on trsp for survival was replaced with
a dependence on trspti6A⫺. This mouse carried 20 copies of a
mutant trsp transgene (trspti6A⫺) and synthesized elevated
amounts of a single form of Sec tRNA[Ser]Sec that lacked i6A37
and, importantly, Um34 (8, 11). The control mouse encoded 20
copies of the wild type transgene (trspt) and synthesized elevated amounts of wild type Sec tRNA[Ser]Sec. These knock-out
transgenic mice were designated as rescued mice. To maintain
rescued mice with the same number of wild type or mutant
transgenes, matings were carried out in the following manner.
Mice in which selenoprotein expression was rescued with the
mutant transgene were generated by mating parents wherein
one parent contained the genotype trsp/⌬trsp-trspti6A⫺/
trspti6A⫺, and the other parent contained the genotype trsp/
⌬trsp-trspti6A⫺/⫹. Offspring with genotype ⌬trsp/⌬trsptrspti6A⫺/⫹ were selected and used for analysis. Mice in which
selenoprotein expression was rescued with the wild type transgene were generated by mating parents wherein both parental
strains contained the genotype trsp/⌬trsp-trspt/trspt and selecting for offspring with genotype ⌬trsp/⌬trsp-trspt/trspt. Mice
that were homozygous ⌬trsp-trspt were mated to maintain a
stable breeding population. Wild type, control mice (genotype
trsp/trsp; designated trsp) were obtained from breedings of
parents with the genotype trsp/⌬trsp-trspt/trsp⫹. Genotypes of
the rescued mice were determined as described under “Experimental Procedures.”
Sec tRNA[Ser]Sec Expression—Transfer RNA was isolated
from the livers of mice with genotype trsp, ⌬trsp-trspt (hereafter designated trspt) and ⌬trsp-trspti6A⫺ (hereafter designated
trspt-i6A⫺) and the Sec tRNA[Ser]Sec population analyzed by

RPC-5 chromatography (Fig. 1). The Sec tRNA[Ser]Sec population in liver of trsp mice consisted of two isoforms. The earlier
eluting tRNA contained mcm5U, and the latter eluting form
contained mcm5Um (see Refs. 11 and 30 and references
therein). The distribution of the two isoforms and the percentage of the Sec tRNA[Ser]Sec population relative to the total
seryl-tRNA population were consistent with previous data for
the Sec tRNA[Ser]Sec population in liver of trsp mice (see Refs.
11 and 30 and references therein). The distributions of the
isoforms synthesized from trspt, which contained much more of
the mcm5U isoform (Fig. 1), were similar to those observed in
previous studies employing transgenic mice carrying 20 copies
of trspt (11). Since the wild type transgene carries a pyrimidine
transition at position 9 (U 3 C), we confirmed that this mouse
synthesized only Sec tRNA[Ser]Sec from trspt by primer extension (data not shown). The i6A⫺ isoform is less hydrophobic
than its i6A37-containing counterparts, and it elutes much
earlier from the column (11). There was no evidence of synthesis of wild type Sec tRNA[Ser]Sec nor of the expression of any
other modified isoform of the i6A-deficient species in mice carrying the i6A⫺ mutant transgene (see also Ref. 8). Furthermore, Um34 cannot be synthesized in i6A⫺ tRNA[Ser]Sec (8), and
the peak of Sec tRNA[Ser]Sec from liver of mice with genotype
trspti6A⫺ shown in Fig. 1 consists of a single isoform lacking
this methyl modification (11, 30). The amount of this isoform
relative to the seryl-tRNA population in liver was consistent
with that observed previously in mice carrying the same number of trspti6A⫺ transgenes (11). Overall, these data established
that only the mutant transgene lacking i6A37 and Um34 was
expressed in mice with genotype trspti6A⫺, whereas a mixture
of the wild type Sec tRNA[Ser]Sec forms that were either methylated or unmethylated on the ribosyl moiety at position 34
were expressed in mice with genotype trspt. Thus, the lack of
i6A37 and Um34 in mice carrying trspti6A⫺ did not result
in lethality.
75
Se Labeling—The expression of selenoproteins in several
tissues of mice with genotype trsp, trspt, or trspti6A⫺ was analyzed by labeling animals with 75Se and examining the resulting labeled proteins following gel electrophoresis. Coomassie
Blue-stained gels of total proteins from each tissue were compared with their same-tissue counterparts and found to be
similar (Fig. 2), suggesting that mice encoding null trsp and
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FIG. 2. 75Se-Labeling and selenoprotein analysis. Mice were labeled with 75Se, and protein was extracted from the tissues in A and B as
shown, electrophoresed, and stained with Coomassie Blue to detect total protein from tissues of trsp, trspt, and trspti6A⫺ mice (see lower panels in
each tissue) and 75Se-labeled proteins detected from the same tissues with a PhosphorImager (see upper panels in each tissue) as described under
“Experimental Procedures.” Protein marker sizes are shown on the left of the panels as indicated by the arrows, and identified selenoproteins are
shown on the right of the panels.

rescued with trspt or trspti6A⫺ did not exhibit major differences
in protein synthesis as a whole (see also Refs. 11, 30, 31).
Examination of 75Se-labeled selenoproteins, however, showed
differences in the patterns of labeling within the same tissues
of wild type and rescued mice. These differences were particularly apparent between tissues from mice with genotype trsp
and trspti6A⫺ and between mice with genotype trspt and
trspti6A⫺. TR1, GPx1, GPx4, and Sep15 have been characterized previously in mammalian cells in culture (35) and in
mammalian tissues (11, 31). The location of these selenoproteins is designated on the liver panel in Fig. 2, and that of
Sep15 is also designated on the testes panel. SelP and GPx3
have been characterized in plasma (see Ref. 31 and references
therein) and are designated on the plasma panel in Fig. 2.
Dramatic differences in selenoprotein labeling patterns were
observed between mice carrying trsp (both wild type and those
carrying trspt) and mice with genotype trspti6A⫺. GPx1 was
poorly rescued and was essentially undetectable in the tissues
examined, and GPx3 was absent in plasma. Expression of two
other selenoproteins was significantly reduced as observed
from 75Se labeling. The 75Se-labeled band at approximately ⬃9
kDa (most likely SelW, based on its size (13)) in liver, testis,
lung, and spleen is absent in mice carrying trspti6A⫺. It was
designated as SelW with a question mark in the liver panel. The
band at ⬃32 kDa was absent in testes of mice with genotype
trspti6A⫺, and this band may be the nuclear form of GPx4 (see
“Western Blot Analyses”). Other selenoproteins such as GPx4
in liver, kidney, testes, lung, and heart appeared to be only
partially rescued in mice with genotype trspti6A⫺. The band
that migrated at ⬃49 kDa and just below TR1 may be SelP
and/or SPS2 based on their molecular size (13). This band was
reduced in liver, kidney, and spleen of mice with genotype
trspti6A⫺. In tissues such as heart and lung, this band appeared to be reduced, whereas the slightly slower migrating
band (presumably TR1) appeared to be enriched in mice with
genotype trspti6A⫺ (see also this latter band in spleen). The
identity of the band at ⬃49 kDa and the possible enrichment of
TR1 in these tissues was not further examined.
The selenoprotein labeling patterns in tissues from trsp and
trspt mice were very similar in most cases, with the possible
exceptions of testes and heart, where GPx1 appeared to en-

riched, and plasma, where GPx3 appeared to be enriched in the
rescued mouse carrying trspt.
Western Blot Analyses—Rescue of selenoproteins was also
examined by Western blotting (Fig. 3). Further confirmation
that GPx1 was virtually absent in mice carrying trspti6A⫺, as
observed in the 75Se-labeling patterns, was obtained by examining GPx1 levels in liver and kidney by Western analysis.
Clearly, GPx1 was not expressed in mice carrying trspti6A⫺.
SelR and SelT were also not rescued, whereas GPx2, GPx4, and
Sep15 appeared to be only partially rescued in mice carrying
trspti6A⫺. The Western blot of GPx4 in testis was overexposed
in order that the slower migrating nuclear GPx4 could be
visualized. It was not rescued in mice carrying trspti6A⫺.
Other selenoproteins examined by Western analysis showed
that TR1 and TR3 were expressed in normal amounts in liver,
kidney, and brain of trspti6A⫺ mice.
Taken together, the Western data established that the expression of several selenoproteins was inhibited, whereas that
of several others was not affected by replacing trsp with
trspti6A⫺.
Northern Blot Analyses—The levels of several mRNAs,
GPx1, GPx2, GPx3, SelR, SelT, and SelW, were reduced in mice
carrying trspti6A⫺ (Fig. 4). Levels of other selenoprotein
mRNAs, such as SelH and SelS, and possibly SelM, SelV, and
TR2 also appeared to be down in mice carrying trspti6A⫺,
suggesting that these proteins, along with GPx2, GPx3, SelR,
SelT, and SelW, may not be rescued or may be only partially
rescued. DI1, GPx4, SelK, SelP, and Sep15 appeared to have
similar amounts of mRNA in mice carrying trsp and trspi6A⫺.
The observation that some mRNA levels appeared to be unaffected is interesting in light of the fact that the corresponding
selenoproteins, namely GPx4, SelP, and Sep15, are only partially rescued as demonstrated by 75Se-labeling and/or Western
blot analysis (see above). In addition, some selenoprotein
mRNAs, such as SelM, SelT, and TR1, appeared to be enriched
in mice carrying trspt (Fig. 4).
Glutathione Peroxidase Activities—It was surprising to find
that GPx1, GPx2, and GPx3 appeared to be slightly enriched as
observed by 75Se-labeling and/or Western blot analysis in certain tissues in mice carrying trspt (see above), since previous
studies suggested that Sec tRNA[Ser]Sec was not limiting in
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TABLE I
Glutathione peroxidase activity
GPx activity was measured as described under “Experimental Procedures.” Each assay was carried out in duplicate, and the numbers
represent the average of these two values. The two activities for each
tissue represent values obtained from two different mice with the same
genotype.
GPx activitya
Tissue

Liver
Kidney
Plasma
Heart
Intestine

FIG. 3. Western blot analyses. Protein extracts were prepared from
the tissues shown of mice carrying trsp, trspt, and trspti6A⫺, electrophoresed, transblotted onto membranes, and treated with the appropriate antibodies as described under “Experimental Procedures.” Selenoproteins are shown on the left of the panels.

FIG. 4. Northern blot analyses. RNA was extracted from tissues of
mice carrying trsp, trspt, and trspti6A⫺, electrophoresed on gels, transblotted onto membranes, and hybridized with the appropriate probe,
and the amount of labeling was determined on a PhosphorImager as
given under “Experimental Procedures.” Staining of developed gels
with ethidium bromide showed virtually identical amounts of 18 and 28
S rRNA present in all tissue extracts (data not shown), demonstrating
that the same amounts of RNA were loaded onto gels. Each of the above
Northern blots was carried out at least three separate times with
tissues from different mice with similar results.

selenoprotein biosynthesis (11, 29, 36). To further assess the
enrichment of the glutathione peroxidases, we assayed their
activity in various tissues (Table I). The assay did not distinguish between the different peroxidases but did assess whether
GPx activity was increased or decreased. GPx (most likely
GPx1) activity appeared to be only slightly increased in liver
and heart, but not in kidney. The highest increase in GPx
activity (most likely GPx2) was observed in intestine. Although

trsp

trspt

trspti6A⫺

94.9
114.0
125.3
116.3
600.8
416.0
7.5
12.1
9.2
11.9

113.8
159.6
116.5
135.2
790.4
444.9
10.7
13.4
15.3
12.5

3.1
3.6
9.1
3.0
52.7
37.5
4.8
3.0
0.9
0.6

a
GPx activities are expressed as nmol of NADPH/min/mg of protein
for liver, kidney, heart, and intestine. Plasma values are expressed as
nmol of NADPH/min/ml.
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Se labeling of selenoproteins suggested that GPx3 might be
enriched in plasma of mice carrying trspt (see Fig. 2), its activity was increased only slightly. Further studies are needed,
however, to examine increases in GPx expression and activity
due to overexpression of Sec tRNA[Ser]Sec.
Selenium Status—Selenium levels in liver, heart, brain, and
testes of mice carrying trsp, trspt, and trspti6A⫺ were determined. The amounts of this element were reduced in these
tissues of mice carrying trspti6A⫺ as compared with the corresponding tissues for wild type mice as shown in Fig. 5. The
greatest loss in selenium content, as well as relative overall
loss, was in liver of mice carrying trspti6A⫺. The relative loss in
the brain and testes was surprisingly greater than that in the
heart, since the former two tissues are known to maintain their
selenium levels in virtually the same amounts even when the
animal is subjected to selenium-deficient diets (37, 38). On the
other hand, the levels of this element in heart and liver are
responsive to selenium status and manifest reduced levels during conditions of selenium deficiency (37, 38).
Litter Sizes and Male Fertility—Matings between wild type
mice and mice carrying trspt resulted in normal litter sizes of
about eight offspring. Matings between mice carrying
trspti6A⫺, however, resulted in few pregnancies and in only one
or two offspring when the mating was successful. Therefore,
the sperm from two male mice carrying trspti6A⫺ was analyzed
and compared with sperm from mice carrying trsp and trspt.
The sperm from wild type males and males carrying trspt had
greater than 90% normal morphology (data not shown). A value
of ⬃10% abnormal morphology in sperm is not unusual for the
wild type mice used in this study.3 Sperm from the trspti6A⫺
mice, however, had a high percentage of cells with distorted
morphology that probably accounted for their low fertility (see
Table II). Matings between females rescued with the mutant
transgene and males carrying one copy of trsp and heterozygous or homozygous for trspti6A⫺ yielded smaller litter sizes
with an average of four mice/litter. Analysis of sperm showed
normal morphology (data not shown), suggesting that females
rescued with the mutant transgene had some aberration with
fertility and/or pregnancy to term. The observation regarding
the reduced number of pregnancies and litter sizes was not
further examined. Otherwise, the phenotypes of mice rescued
with the mutant transgene appeared to be normal.
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FIG. 5. Selenium levels in tissues of mice carrying trsp, trspt,
and trspti6Aⴚ. The amount of selenium was determined in duplicate in
liver, heart, brain, and testes, and the values represent the average of
assays from two separate animals of the same genotype.
TABLE II
Sperm analysis
Sperm analysis was carried as described previously (46). The sperm
of two male mice of each genotype, trsp, trspt, trspti6A⫺, and trsp⌬trsptrspti6A⫺/⫹, were examined. Sperm from all males had greater than 90%
normal morphology except those of rescued mice with genotype
trspti6A⫺ as shown in the table.
Morphology
Genotype

Age

Sperm count
Normal

Days

trspti6A- 132
t 6

trsp i A- 398

Bent tailsa

Heads and tails
separated

%

%

%

45 ⫻ 106

41

56

3

38 ⫻ 10

39

55

6

6

a

Bent tails designates aberrant sperm with abnormal and bent tails
with cytoplasmic droplets.
DISCUSSION

Removal of trsp from the mouse genome is embryonic lethal
(29, 30). However, as shown in the present study, such mice can
be rescued with either wild type or mutant transgenes without
significantly affecting animal viability. Surprisingly, mice dependent on the mutant Sec tRNA[Ser]Sec transgene expressed
some, but not all, selenoproteins. The mutant tRNA[Ser]Sec
lacked i6A37 and, as a consequence, was incapable of forming
Um34 (8). The expression of a subset of selenoproteins is therefore dependent on one or both of these modifications. The
pronounced effect of such an alteration(s) in tRNA on protein
synthesis has not been previously observed.
Since the single species of tRNA[Ser]Sec in mice carrying
trspti6A⫺ lacks both i6A and Um34, questions may be raised of
which one of these two modifications (if not both) influence
selenoprotein expression in the manner observed in this study.
Clearly, the isoform lacking i6A is efficiently utilized in protein
synthesis, but only expressing selenoproteins such as TR1,
TR3, and GPx4. The Sec tRNA[Ser]Sec pool is missing Um34,
and the loss of this methyl group is correlated with the downregulation of several stress-related selenoproteins such as
GPx1, GPx3, SelR, SelT, and SelW. Furthermore, the addition
[Ser]Sec
of Um34 to tRNAmcmU
requires selenium, and selenium-deficient mice not only have reduced levels of the mcm5Um isoform
but also have reduced levels of several of the poorly translated
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selenoproteins (reviewed in Ref. 2) identified in this study. This
hierarchy in selenoprotein synthesis (see Refs. 2 and 3 and this
study) correlates with the presence of Um34, but not i6A37. In
addition, the synthesis of the methyl group on the mcm5Um
isoform is a highly specialized event in selenoprotein expression as noted in the Introduction. It is of significance to emphasize three earlier studies that show a direct correlation
between the levels of Um34 on tRNA[Ser]Sec and GPx1. Replenishment of selenium-deficient rats with this element showed a
[Ser]Sec
direct correlation between increasing amounts of tRNAmcmUm
and GPx1 (10). Transgenic mice encoding the Sec tRNA[Ser]Sec
i6A37 minus transgene manifested a pronounced decrease in
both the Um34 isoform and GPx1 (11). More recently, a study
by Jameson and Diamond (12) demonstrated a preferential use
[Ser]Sec
of tRNAmcmUm
in selenoprotein synthesis when GPx1 was overexpressed. Therefore, the evidence supports a role of this
methyl group in the synthesis of several selenoproteins that are
down-regulated in the rescue mouse described in this study.
Caution must be exercised in the interpretation that Um34 is
solely responsible for the observed effects, since we cannot rule
out a possible influence of i6A37. However, the Um34 modification clearly has a dramatic influence on selenoprotein expression as evidenced by the occurrence of similar selenoprotein levels detected during selenium deficiency and in the loss
of Um34 on Sec tRNA[Ser]Sec in the present study.
How then can the absence of Um34 play a major role in the
expression of some, but not all, selenoproteins? An examination
of many different parameters that might be involved in decoding efficiency of the selenoproteins identified in the present
study as being poorly translated in rescued mice (GPx1, GPx3,
SelR, SelT, and SelW), partially translated (GPx2, GPx4, SelP,
and Sep15), and efficiently expressed (TR1 and TR3) as well as
the 13 other selenoproteins in mice (13) did not reveal any
specific pattern that would appear to influence translation.
Other features such as the possibility of specific SECIS-binding
proteins that could act specifically on different selenoproteins
will have to await further investigation. The finding in the
present study, however, that the presence of two Sec isoforms
differing by a methyl group are utilized differently in selenoprotein biosynthesis is highly significant and demonstrates a
unique manner in which Sec machinery has evolved in higher
animals to express this class of proteins under conditions of
selenium deprivation.
The mice that were rescued with the mutant Sec tRNA[Ser]Sec
transgene in this study appeared to have a normal phenotype
with the exception of reduced fertility in males and an apparent
reduced litter size in females. The loss of the nuclear form of
GPx4 and the reduced levels of GPx4 in testes probably contributed to the loss in male fertility. In addition, these results
provide further evidence of a direct role of selenium in mammalian male fertility (39). Mice dependent on trspti6A⫺ were
also selenium-deficient in the organs tested, suggesting that
most of the selenium content of tissues is contained in selenoproteins. These observations are consistent with an earlier
study in which the targeted removal of selenoprotein expression in mouse liver resulted in the loss of most of the selenium
in this organ, whereas the amount of small molecular weight
selenocompounds did not change from that found in wild type
livers (see Ref. 31 and references therein).
Mammalian selenium-containing proteins respond to
changes in selenium status in a selenoprotein- and tissuespecific manner, but the mechanisms for this hierarchy (2, 3)
and specific roles of many selenoproteins (13) have not been
resolved. Our data suggest that the biosynthesis of GPx1,
[Ser]Sec
GPx3, SelR, SelT, and SelW is dependent on tRNAmcmUm
,
whereas that of others, such as TR1 and TR3, is not. The group
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of selenoproteins that are not rescued in the trspti6A⫺ mice
includes stress-related selenoproteins, GPx1, GPx3, and SelR,
whereas SelT and SelW also probably fall into this category.
Expression of several of these proteins is known to be affected
by selenium deficiency, which also results in decreased levels of
their mRNAs due to nonsense-mediated decay (40, 41). The
data presented herein also suggest that some selenoproteins
such as GPx4, Sep15, and SelP are partially rescued, but their
mRNA levels were not affected. Determination of whether
selenoprotein hierarchy may be regulated by Um34 in Sec
tRNA[Ser]Sec and whether the corresponding mRNAs may not
be translated and subject to nonsense-mediated decay, and
therefore whether the second event is the result of the first,
must await further study.
The group of selenoproteins that were fully rescued in the
trspti6A⫺ mice included TR1 and TR3 that are less affected by
selenium deficiency (2, 3). TR1 and TR3 control the redox state
of cytosolic and mitochondrial thioredoxins, respectively, which
are essential mammalian proteins.
Nucleoside modifications within the tRNA anticodon loop
have been associated with a variety of effects on translation
(reviewed in Ref. 42). In higher eukaryotes, such modifications
have been shown to influence ribosomal frame shifting (43) and
suppression of nonsense codons (44, 45). Although we have
known for many years that the methyl modification at position
34 in Sec tRNA[Ser]Sec is a highly specialized event (see Introduction), this study provides the first example of translation of
a number of mRNAs being dependent on the recoding of an
in-frame nonsense codon by Um34 and describes a new and
novel role of tRNA modification in the recoding process.
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